Document is current
Any future updates will be listed below
-
Authors
Spicer, James http://orcid.org/0000-0003-3732-8491
Basu, Bristi
Montes, Ana
Banerji, Udai http://orcid.org/0000-0003-1503-3123
Kristeleit, Rebecca http://orcid.org/0000-0003-3825-1326
Miller, Rowan http://orcid.org/0000-0002-2400-1716
Veal, Gareth J.
Corrigan, Christopher J. http://orcid.org/0000-0002-0706-6534
Till, Stephen J.
Figini, Mariangela http://orcid.org/0000-0001-9001-8754
Canevari, Silvana http://orcid.org/0000-0002-2963-3587
Barton, Claire
Jones, Paul
Mellor, Sarah
Carroll, Simon
Selkirk, Chris
Nintos, George
Kwatra, Vineet
Funingana, Ionut-Gabriel http://orcid.org/0000-0002-1197-2652
Doherty, Gary http://orcid.org/0000-0002-8158-8111
Gould, Hannah J. http://orcid.org/0000-0003-0411-688X
Pellizzari, Giulia http://orcid.org/0000-0003-0387-1912
Nakamura, Mano http://orcid.org/0000-0002-0699-6799
Ilieva, Kristina M.
Khiabany, Atousa
Stavraka, Chara
Chauhan, Jitesh
Gillett, Cheryl
Pinder, Sarah http://orcid.org/0000-0003-4167-8910
Bax, Heather J. http://orcid.org/0000-0003-0432-4160
Josephs, Debra H.
Karagiannis, Sophia N. http://orcid.org/0000-0002-4100-7810
-
Funding
Funding for this research was provided by:
Cancer Research UK (N/A)
- License Information
-
More Information
Article History
Received: 2 March 2023
Accepted: 22 June 2023
First Online: 25 July 2023
Competing interests
: J.S. and S.K. are co-founders of Epsilogen Ltd. H.B. is presently employed, and J.C. formerly employed, through a fund from Epsilogen Ltd. S.K., H.B., H.G., D.J, G.P. and J.S. hold patents on anti-tumour IgE antibodies. The remaining authors declare no competing interests.
